Pharmaceutical and Biotech Gross-to-Net Finance Operations.

October 16-17, 2019 | USA

Achieving GTN optimization requires a model that supports new product launches, forecasts revenue, contributes to the understanding of customers and commercial levers via identifying customer dynamics that influence pricing and contracting, as well as implementing process improvement with a focus on internal controls, policies, and procedures.

Spotlight

Collaborations among academic and government researchers, pharmaceutical and biotechnology companies, regulatory agencies, and patients and their families are crucial to research and development of therapeutics for rare diseases. Industry, academic and government researchers, regulatory agencies, patients and their caregivers all confront challenges in today’s environment for therapeutic development. As a result, the stakeholders are realizing the increasing value in collaborations, which can help tackle these challenges.


OTHER PAST CONFERENCES

DIGI-TECH PHARMA And AI 2022

May 10-11, 2022 | USA

The Digi-Tech Pharma & AI 2022 conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry.

Pharmaceutical Mobile Robotics

April 21-22, 2022 | UK

Enabling The Development Of Plug and Play Robotics and Advancing Innovation In QC Labs Of The Future, Pharma Logistics & Automation

INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES

June 6-7, 2022 | Mauritius

Welcome to the official website of from World Academics. will be held in Port Louis, Mauritius during 6th June-7th June 2022. .

International Conference on Pharmaceutical Chemistry

April 24, 2022 | Seychelles

IIERD is aimed at providing a platform to discuss and enhance the developments in science, technology, management and allied areas to strengthen the core of research with new ideas to nurture.

Spotlight

Collaborations among academic and government researchers, pharmaceutical and biotechnology companies, regulatory agencies, and patients and their families are crucial to research and development of therapeutics for rare diseases. Industry, academic and government researchers, regulatory agencies, patients and their caregivers all confront challenges in today’s environment for therapeutic development. As a result, the stakeholders are realizing the increasing value in collaborations, which can help tackle these challenges.

resources